These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11862759)

  • 1. [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent].
    Shirakawa K
    Nihon Yakurigaku Zasshi; 2002 Feb; 119(2):111-8. PubMed ID: 11862759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents.
    Sanger DJ
    CNS Drugs; 2004; 18 Suppl 1():9-15; discussion 41, 43-5. PubMed ID: 15291009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem].
    Benavides J; Depoortere H; Sanger D; Perrault G; Arbilla S; Langer SZ; Zivkovic B; Scatton B
    Encephale; 1990; 16(1):13-22. PubMed ID: 2158421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.
    Perrault G; Morel E; Sanger DJ; Zivkovic B
    Eur J Pharmacol; 1990 Oct; 187(3):487-94. PubMed ID: 1981555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomnographic effects of hypnotic drugs. A review.
    Parrino L; Terzano MG
    Psychopharmacology (Berl); 1996 Jul; 126(1):1-16. PubMed ID: 8853211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem: a review of its use in the management of insomnia.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(1):65-89. PubMed ID: 15651908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.
    Langtry HD; Benfield P
    Drugs; 1990 Aug; 40(2):291-313. PubMed ID: 2226217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity within the GABAA receptor supramolecular complex: a consideration of the new omega 1-receptor selective imidazopyridine hypnotic zolpidem.
    Lloyd KG; Zivkovic B
    Pharmacol Biochem Behav; 1988 Apr; 29(4):781-3. PubMed ID: 2842810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management.
    Liappas IA; Malitas PN; Dimopoulos NP; Gitsa OE; Liappas AI; Nikolaou ChK; Christodoulou GN
    J Psychopharmacol; 2003 Mar; 17(1):131-5. PubMed ID: 12680751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.
    Sanger DJ; Perrault G; Morel E; Joly D; Zivkovic B
    Physiol Behav; 1987; 41(3):235-40. PubMed ID: 3324120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
    Parrino L; Boselli M; Spaggiari MC; Smerieri A; Terzano MG
    Clin Neuropharmacol; 1997 Jun; 20(3):253-63. PubMed ID: 9197949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
    Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
    J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.